The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Focus article

Rationale and use of antiplatelet and antithrombotic drugs during cardiovascular interventions

EuroIntervention 2008;4:183-186 - DOI10.4244/EIJV4I2A33.

1. Department of Cardiology, University Hospital La Timone, Marseille, France; 2. Department of Cardiology, Pulmonology and Internal Intensive Care Medicine, Städtisches Klinikum München GmbH, Klinikum Neuperlach, Munich, Germany; 3. Cardiovascular Center

Recent European Society of Cardiology (ESC) Guidelines have extensively investigated antithrombotic therapy during percutaneous coronary interventions (PCI)1-3. However, based on the

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Read next article
Radiation safety during percutaneous coronary procedures: how to reduce radiation exposure and its complications